Uceris Aerosol, Foam
Product Images NDC 65649-651

14 FDA label images from Salix Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Uceris (NDC 65649-651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Salix Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Image 02)

Formula (Image 02)
Chemical structure diagram of budesonide, the active ingredient in Uceris 2 mg/1 aerosol foam. The diagram shows the molecular arrangement and bonding of its steroid scaffold with various functional groups.*
FDA Label Image

Instructions For Use (Image 03)

Instructions For Use (Image 03)
This illustration shows the packaging and components of Uceris 2 mg/1 aerosol foam by Salix Pharmaceuticals. It includes disposal bags, four trays each holding single-use applicators, and an aerosol canister with labeled parts: dome, safety tab, nozzle, and applicator. The image visually describes the product's components for rectal administration.*
FDA Label Image

Budesonide-6 (Image 13)

Budesonide-6 (Image 13)
An instructional diagram showing the use of a rectal applicator. The image depicts the insertion or positioning step with an arrow indicating the direction of movement. This illustration is related to Uceris 2 mg/1 aerosol foam rectal use instructions by Salix Pharmaceuticals, Inc.*
FDA Label Image

Budesonide-8 (Image 14)

Budesonide-8 (Image 14)
An instructional illustration showing the correct attachment of a nozzle to a foam aerosol bottle. A blue arrow points from the nozzle toward the top of the bottle, indicating where to insert the nozzle for use.*
FDA Label Image

Figure D (Image 04)

Figure D (Image 04)
An instructional illustration showing the top part of an aerosol foam dispenser with a semicircular notch marked by an arrow. The image highlights how to align or operate the dispenser's top by rotating it in the direction indicated by an arrow around the knob.*
FDA Label Image

Ifu-fige (Image 05)

Ifu-fige (Image 05)
An instructional illustration showing a hand firmly pressing down on a foam aerosol canister with a stopwatch icon indicating to hold the press for 10 to 15 seconds. This likely relates to proper administration technique for the rectal foam product Uceris (budesonide).*
FDA Label Image

Ifu6 (Image 06)

Ifu6 (Image 06)
An instructional illustration showing a hand holding a Uceris aerosol foam applicator for rectal use. The image demonstrates how to grip the applicator and prepare it for administration by pressing down on the tube to dispense foam.*
FDA Label Image

Figure G (Image 07)

Figure G (Image 07)
An instructional illustration showing the use of a rectal aerosol foam device, positioned near the anal opening, with a finger pressing the applicator to deliver medication in a rectal administration route.*
FDA Label Image

Figure H (Image 08)

Figure H (Image 08)
The illustration diagram depicts a hand holding and pressing an applicator device against the rectal area, indicating to press only one time. Next to the image, there is a stopwatch icon with the text '2 SECONDS,' suggesting the duration for holding the press. This visual likely instructs the user on proper application technique for a rectal foam product.*
FDA Label Image

Ifu-figi (Image 09)

Ifu-figi (Image 09)
An instructional illustration showing the application of a rectal aerosol foam, depicting a hand spraying the foam into the rectal area. To the right of the image, a stopwatch icon indicates a wait time of 10 to 15 seconds.*
FDA Label Image

Ifu-figj (Image 10)

Ifu-figj (Image 10)
An instructional illustration showing the hand insertion of a rectal foam applicator into the anus. The image highlights the correct placement with the applicator being inserted and an arrow pointing outward, indicating the direction to pull back after use.*
FDA Label Image

Ifu-figk (Image 11)

Ifu-figk (Image 11)
An instructional diagram showing a syringe-like applicator being inserted into or withdrawn from a rectangular pouch or package opening, likely illustrating the use or assembly of a medication delivery device such as for Uceris rectal foam.*
FDA Label Image

Figurel (Image 12)

Figurel (Image 12)
An instructional illustration showing a close-up of an aerosol foam dispenser's top. It features a circular cap with an arrow indicating the direction to turn or remove the cap, and a horizontal nozzle protruding from the base.*
FDA Label Image

Carton (Image 01)

Carton (Image 01)
Uceris 2 mg/actuation budesonide rectal foam packaging label by Salix Pharmaceuticals, Inc. This is for a human prescription drug, rectal administration, with each kit containing two 33.4 g canisters of foam with 22 PVC applicators. The label includes product identification, storage instructions, and brief usage illustrations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.